Vic Neufeld of Aphria is part of this year's Wealth Professional Canada's Hot List.
The best-performing stock on the TSX in 2017 in terms of total returns was medical marijuana producer Aphria. Investors in the firm enjoyed a 271% return last year, and that momentum has carried forward into this year.
With recreational legalization of cannabis looming, Aphria CEO Vic Neufeld is thinking expansion: “Looking ahead, our focus remains on exploring strategic opportunities and partnerships globally while continuing our extensive preparations for the coming legalization of the adult-use market in Canada,” he said recently. “Backed by expertly researched consumer insights, we will begin to introduce our diverse portfolio of adult-use brands, while continuing to support our extensive product mix and patient base on the medical side.”